Navigation Links
3-drug combination 'extremely promising' as first-line therapy for multiple myeloma
Date:12/11/2007

ATLANTAA new combination of bortezomib (Velcade) and two other drugs is showing a very high response rate in patients newly diagnosed with multiple myeloma, a team headed by Dana-Farber Cancer Institute investigators reported at the annual meeting of the American Society of Hematology.

The three-pronged regimen of Velcade, lenalidomide (Revlimid) and dexamethasone referred to as Rev/Vel/Dex has achieved an overall response rate of 98 percent in 42 patients evaluated thus far in a Phase 1-2 trial, said Paul Richardson, MD, of Dana-Farber and the studys principal investigator. He added that 52 percent of the patients had high quality responses (very good partial response or better), with 30 percent achieving complete response to date.

These may be some of the best response rates weve seen to date with up-front therapies, and although these are preliminary results, they are extremely promising, Richardson said. The patients were previously untreated when they received the Rev/Vel/Dex combination.

Velcade is a smart drug known as a proteasome inhibitor that blocks the myeloma cells waste disposal system, creating an accumulation of toxic compounds that poison the cell. Revlimid is a chemical relative of thalidomide that affects several pathways in cancer cells, including immune mechanisms and blood vessel growth to tumors. Dexamethasone is a steroid hormone that counters inflammation and is used to treat hematologic malignancies such as myeloma. Studies leading to the trial of the three drugs in combination were carried out at Dana-Farber.

While these are the first results from trials of Rev/Vel/Dex given as initial, first-line therapy for the blood cancer, the combination has already been shown effective for multiple myeloma patients who had relapsed following successful treatment or who had not responded to standard therapies.

Richardson also reported at the ASH meeting preliminary data from a Dana-Farber led mul
'/>"/>

Contact: Teresa Herbert
617-632-4090
Dana-Farber Cancer Institute
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Promising drug combination may help those with ocular melanoma that has spread
2. Combination therapy reverses effects of portal hypertension in rats
3. Combination vaccines okay for infants, study shows
4. Antidepressants and painkillers - a dangerous combination
5. Intra-arterial combination chemotherapy induces long-term survival for hepatocellular carcinoma
6. U.S. Oncology Initiates Complete Phase Ib Trial of Brostallicin Combination Therapy in Advanced Solid Tumors
7. Drug combination might offer hope for patients deadly brain tumors
8. EpiCept to Present Preclinical Studies of EPC2407 in Combination With Anti-Angiogenic and Chemotherpeutic Agents at the AACR-NCI-EORTC International Conference
9. Combination targets: some drugs may work best when they work together
10. MAP Pharmaceuticals Initiates Phase 2a Clinical Trial of Combination Therapy in Adult Patients with Asthma
11. Quality Control: Nissan Quest to Feature micronAir(R) Combination Cabin Air Filters
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... (PRWEB) March 31, 2015 On November 24, ... All-Pro Lawrence Taylor to discuss the problem of substance abuse ... his own history of drug abuse and recovery, gives a ... Nicknamed “L.T.” by his teammates on the New York Giants, ... due to failed drug tests, yet he was able to ...
(Date:3/31/2015)... Angeles, CA (PRWEB) March 31, 2015 Dr. Parsa ... the pioneering hair transplant surgeons on the forefront of using ... A procedure once thought of, as a novelty has now become ... it comes to their hairlines. “I really do believe that beard ... a hair transplant if their donor area isn’t as dense as ...
(Date:3/31/2015)... Karen A. Daley, Ph.D. will address graduates ... Commencement ceremony on May 9, 2015 and will ... of her eminent career as a nurse, public health ... and senior staff nurse at Brigham and Women’s Hospital ... roles, including President of the American Nurses Association in ...
(Date:3/31/2015)... (PRWEB) March 31, 2015 Medical DNA ... has met all criteria for Laboratory Accreditation by COLA, ... only to laboratories that apply rigid standards of quality ... of proficiency testing, and pass a rigorous on-site laboratory ... accreditation as a result of a long-term commitment to ...
(Date:3/31/2015)... Los Angeles, CA (PRWEB) March 31, 2015 ... titled “Would You Go Down the Silicone Slope?” provides a ... , dermal filler , and laser treatments . ... an example) and reality TV stars such as Kim Kardashian ... and other social media are increasingly seen as significant influences ...
Breaking Medicine News(10 mins):Health News:Lawrence Taylor & Per Wickstrom Discuss the Drug Rehabilitation & Recovery Process 2Health News:Is Beard to Scalp Hair Transplant the Future? 2Health News:Rivier University to recognize nurse leader, educator and safety advocate at 80th Commencement on May 9th 2Health News:Rivier University to recognize nurse leader, educator and safety advocate at 80th Commencement on May 9th 3Health News:Local Medical DNA Labs, LLC. Recognized for Quality Laboratory Services 2Health News:Cosmetic Surgery: Does Social Media Pressure Young Girls to Get Botox and Fillers? 2
... The following is a statement by Steve Millard , President & Executive Director, Council of Smaller Enterprises (COSE): , ... , , ... ... ...
... Joel A. Gingras, Jr. Award Presented to Joel A. Gingras, Jr. Memorial Fund , ... , , ... ... CHICAGO , March 12 The American Brain Tumor ...
... soon after diagnosis, , FRIDAY, March 12 (HealthDay News) -- ... months of diagnosis -- it appears the drug will remain ... suggests that to gain full benefit from metformin, patients should ... have diabetes," lead author Jonathan B. Brown, an investigator with ...
... ... web sites for his veterinary practice in Delray Beach and Boca Raton, Florida. These sites ... topics. , ... 2010 -- Palm Beach County veterinarian Dr. Arthur Malernee launched a new web site designed ...
... , ... , ... ... DALLAS , March 12 A new grassroots campaign is expected to generate ...
... operations for carcinoma of the rectum. Christian Schmidt et al. ... issue of Deutsches rzteblatt International ( Dtsch Arztebl ... more than 70,000 people develop colorectal carcinoma. The aim of ... on quality of life and sexual function. Data from 368 ...
Cached Medicine News:Health News:What Real Health Care Reform Must Address 2Health News:What Real Health Care Reform Must Address 3Health News:What Real Health Care Reform Must Address 4Health News:What Real Health Care Reform Must Address 5Health News:American Brain Tumor Association Recognizes Philadelphia Family Foundation With Annual Award 2Health News:American Brain Tumor Association Recognizes Philadelphia Family Foundation With Annual Award 3Health News:Start Metformin Early for Best Results 2Health News:Delray Beach and Boca Raton Veterinarian Launches New Web Sites for Atlantic Animal Hospital 2Health News:Think Tank & Radio Network Encourage Massive Resistance to ObamaCare 2Health News:Think Tank & Radio Network Encourage Massive Resistance to ObamaCare 3Health News:Think Tank & Radio Network Encourage Massive Resistance to ObamaCare 4
(Date:3/31/2015)... -- ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ANIP ) ... and 300mg oral tablets, indicated for use in the ... Propafenone Hydrochloride 150mg, 225mg and 300mg tablets was $14 ... Arthur S. Przybyl , President and Chief Executive Officer ... our fourth product from the portfolio of approved generic ...
(Date:3/31/2015)... March 31, 2015  Oxis International, Inc. (OXIS) (OXI.PA) ... and commercialization, announced today Oxis CEO Tony Cataldo ... Oxis common shares on the Euronext exchange. Oxis shares ... symbol OXIS.   Oxis Chairman and CEO ... move forward with its strategies launched in 2014 and ...
(Date:3/31/2015)... DUBLIN , Mar. 27, 2015 Research ... announced the addition of the "North American ... Laboratory Information System), by Type (Clinical Pathology Laboratory ... Forecast to 2019" report to their offering. ... market is estimated to grow at a CAGR ...
Breaking Medicine Technology:ANI Pharmaceuticals Announces the Launch of Propafenone Tablets 2ANI Pharmaceuticals Announces the Launch of Propafenone Tablets 3Oxis International Inc. Announces Request for Euronext Trading Suspension 2North American Laboratory Information System (Clinical Pathology Laboratory Information System, Anatomic Pathology Laboratory Information) Market 2015-2019 2North American Laboratory Information System (Clinical Pathology Laboratory Information System, Anatomic Pathology Laboratory Information) Market 2015-2019 3
... of Senior Notes in Connection with... -- ARDEE, Ireland, Sept. 24 ... ... ... ,; var first_result; // Results are keyed by longUrl, so we need to grab the first one. ...
... MSON ), a developer of state of ... used for acute health conditions, today announced plans to ... financial results on Tuesday, September 28, 2010.  Michael A. ... Senior VP and Chief Financial Officer, will host a ...
Cached Medicine Technology:Warner Chilcott Announces Pricing of $500 Million of Senior Notes in Connection with Agreement to Acquire U.S. Rights to Enablex® 2Warner Chilcott Announces Pricing of $500 Million of Senior Notes in Connection with Agreement to Acquire U.S. Rights to Enablex® 3Warner Chilcott Announces Pricing of $500 Million of Senior Notes in Connection with Agreement to Acquire U.S. Rights to Enablex® 4Warner Chilcott Announces Pricing of $500 Million of Senior Notes in Connection with Agreement to Acquire U.S. Rights to Enablex® 5Warner Chilcott Announces Pricing of $500 Million of Senior Notes in Connection with Agreement to Acquire U.S. Rights to Enablex® 6Warner Chilcott Announces Pricing of $500 Million of Senior Notes in Connection with Agreement to Acquire U.S. Rights to Enablex® 7Warner Chilcott Announces Pricing of $500 Million of Senior Notes in Connection with Agreement to Acquire U.S. Rights to Enablex® 8Misonix Schedules Fourth Quarter and Fiscal 2010 Financial Results Conference Call; September 28, 2010 at 4:30 p.m. Eastern 2
Mcintyre straight lachrymal cannula, closed end, two side ports at 0.3 mm, straight shaft....
McIntyre lacrimal cannula, dual 0.3 mm side ports, straight....
Lacrimal cannula, malleable tip, straight....
Button Tip Manipulator, 0.50 mm diameter button tip, angled 45 degrees, 15 mm from tip to bend....
Medicine Products: